Cargando…

Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients

BACKGROUND: Scoliosis is widely prevalent among osteogenesis imperfecta (OI) patients, and is progressive with age. However, factors affecting scoliosis in OI are not well known. METHODS: We retrospectively retrieved longitudinal radiographic and clinical records of consecutive OI patients seeking t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Peikai, Zhou, Yapeng, Tan, Zhijia, Lin, Yunzhi, Lin, Daniel Li-Liang, Wu, Jingwei, Li, Zeluan, Shek, Hiu Tung, Wu, Jianbin, Hu, Yong, Zhu, Feng, Chan, Danny, Cheung, Kenneth Man-Chee, To, Michael Kai-Tsun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510243/
https://www.ncbi.nlm.nih.gov/pubmed/37730650
http://dx.doi.org/10.1186/s13023-023-02906-z
_version_ 1785107926025764864
author Chen, Peikai
Zhou, Yapeng
Tan, Zhijia
Lin, Yunzhi
Lin, Daniel Li-Liang
Wu, Jingwei
Li, Zeluan
Shek, Hiu Tung
Wu, Jianbin
Hu, Yong
Zhu, Feng
Chan, Danny
Cheung, Kenneth Man-Chee
To, Michael Kai-Tsun
author_facet Chen, Peikai
Zhou, Yapeng
Tan, Zhijia
Lin, Yunzhi
Lin, Daniel Li-Liang
Wu, Jingwei
Li, Zeluan
Shek, Hiu Tung
Wu, Jianbin
Hu, Yong
Zhu, Feng
Chan, Danny
Cheung, Kenneth Man-Chee
To, Michael Kai-Tsun
author_sort Chen, Peikai
collection PubMed
description BACKGROUND: Scoliosis is widely prevalent among osteogenesis imperfecta (OI) patients, and is progressive with age. However, factors affecting scoliosis in OI are not well known. METHODS: We retrospectively retrieved longitudinal radiographic and clinical records of consecutive OI patients seeking treatments at our hospital from 2014 to 2022, graded their pre-operative spinal conditions into four outcome groups, estimated their progression rates, and descriptively and inferentially analyzed the genetic and non-genetic factors that may affect the outcomes and progression rates. RESULTS: In all, 290 OI patients met the inclusion criteria, where 221 had genetic records. Of these 221, about 2/3 had mutations in COL1A1 or COL1A2, followed by mutations in WNT1 (9.0%), IFITM5 (9.0%) and other OI risk genes. With an average age of 12.0 years (interquartile range [IQR] 6.9–16.1), 70.7% of the cohort had scoliosis (Cobb angle > 10°), including 106 (36.5%) mild (10°–25°), 40 (13.8%) moderate (25°–50°), and 59 (20.3%) severe (> 50°) scoliosis patients. Patients with either COL1A1 and COL1A2 were strongly biased toward having mild or no scoliosis, whereas patients with mutations in IFITM5, WNT1 and other recessive genes were more evenly distributed among the four outcome grades. Lower-limb discrepancy, bone mineral density (BMD) and age of first drug used were all significantly correlated with severity outcomes. Using multivariate logistic regression, we estimated that each year older adds an odds ratio of 1.13 (95% confidence interval [CI] 1.07–1.2) in progression into advanced stages of scoliosis. We estimated a cohort-wide progression rate of 2.7 degrees per year (95% CI 2.4–3.0). Early-onset patients experienced fast progressions during both infantile and adolescent stages. Twenty-five of the 59 (42.8%) patients with severe scoliosis underwent spinal surgeries, enjoying an average Cobb angle reduction of 33° (IQR 23–40) postoperatively. CONCLUSION: The severity and progression of scoliosis in osteogenesis imperfecta were affected by genetic factors including genotypes and mutation types, and non-genetic factors including age and BMD. As compared with COL1A1, mutations in COL1A2 were less damaging while those on IFITM5 and other recessive genes conferred damaging effects. Progression rates were the fastest in the adolescent adult age-group. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02906-z.
format Online
Article
Text
id pubmed-10510243
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105102432023-09-21 Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients Chen, Peikai Zhou, Yapeng Tan, Zhijia Lin, Yunzhi Lin, Daniel Li-Liang Wu, Jingwei Li, Zeluan Shek, Hiu Tung Wu, Jianbin Hu, Yong Zhu, Feng Chan, Danny Cheung, Kenneth Man-Chee To, Michael Kai-Tsun Orphanet J Rare Dis Research BACKGROUND: Scoliosis is widely prevalent among osteogenesis imperfecta (OI) patients, and is progressive with age. However, factors affecting scoliosis in OI are not well known. METHODS: We retrospectively retrieved longitudinal radiographic and clinical records of consecutive OI patients seeking treatments at our hospital from 2014 to 2022, graded their pre-operative spinal conditions into four outcome groups, estimated their progression rates, and descriptively and inferentially analyzed the genetic and non-genetic factors that may affect the outcomes and progression rates. RESULTS: In all, 290 OI patients met the inclusion criteria, where 221 had genetic records. Of these 221, about 2/3 had mutations in COL1A1 or COL1A2, followed by mutations in WNT1 (9.0%), IFITM5 (9.0%) and other OI risk genes. With an average age of 12.0 years (interquartile range [IQR] 6.9–16.1), 70.7% of the cohort had scoliosis (Cobb angle > 10°), including 106 (36.5%) mild (10°–25°), 40 (13.8%) moderate (25°–50°), and 59 (20.3%) severe (> 50°) scoliosis patients. Patients with either COL1A1 and COL1A2 were strongly biased toward having mild or no scoliosis, whereas patients with mutations in IFITM5, WNT1 and other recessive genes were more evenly distributed among the four outcome grades. Lower-limb discrepancy, bone mineral density (BMD) and age of first drug used were all significantly correlated with severity outcomes. Using multivariate logistic regression, we estimated that each year older adds an odds ratio of 1.13 (95% confidence interval [CI] 1.07–1.2) in progression into advanced stages of scoliosis. We estimated a cohort-wide progression rate of 2.7 degrees per year (95% CI 2.4–3.0). Early-onset patients experienced fast progressions during both infantile and adolescent stages. Twenty-five of the 59 (42.8%) patients with severe scoliosis underwent spinal surgeries, enjoying an average Cobb angle reduction of 33° (IQR 23–40) postoperatively. CONCLUSION: The severity and progression of scoliosis in osteogenesis imperfecta were affected by genetic factors including genotypes and mutation types, and non-genetic factors including age and BMD. As compared with COL1A1, mutations in COL1A2 were less damaging while those on IFITM5 and other recessive genes conferred damaging effects. Progression rates were the fastest in the adolescent adult age-group. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02906-z. BioMed Central 2023-09-20 /pmc/articles/PMC10510243/ /pubmed/37730650 http://dx.doi.org/10.1186/s13023-023-02906-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chen, Peikai
Zhou, Yapeng
Tan, Zhijia
Lin, Yunzhi
Lin, Daniel Li-Liang
Wu, Jingwei
Li, Zeluan
Shek, Hiu Tung
Wu, Jianbin
Hu, Yong
Zhu, Feng
Chan, Danny
Cheung, Kenneth Man-Chee
To, Michael Kai-Tsun
Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients
title Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients
title_full Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients
title_fullStr Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients
title_full_unstemmed Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients
title_short Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients
title_sort scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510243/
https://www.ncbi.nlm.nih.gov/pubmed/37730650
http://dx.doi.org/10.1186/s13023-023-02906-z
work_keys_str_mv AT chenpeikai scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients
AT zhouyapeng scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients
AT tanzhijia scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients
AT linyunzhi scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients
AT lindanielliliang scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients
AT wujingwei scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients
AT lizeluan scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients
AT shekhiutung scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients
AT wujianbin scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients
AT huyong scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients
AT zhufeng scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients
AT chandanny scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients
AT cheungkennethmanchee scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients
AT tomichaelkaitsun scoliosisinosteogenesisimperfectaidentifyingthegeneticandnongeneticfactorsaffectingseverityandprogressionfromlongitudinaldataof290patients